NCT00958347

Omnifit Hydroxylapatite (HA) Hip Outcomes Study

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 226 (actual)
• Sponsor: Stryker Orthopaedics · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to obtain up to 25 year post-operative data on the Omnifit Hydroxylapatite (HA) Hip System in support of the hypothesis that it is a satisfactory system for reducing implant loosening, permitting tissue bonding onto the hydroxylapatite surfaces of the implant and providing a safe, efficient, and well-functioning hip in a wide spectrum of clinical circumstances.

Conditions

• Arthroplasty, Replacement, Hip

Interventions

Type	Name	Description
DEVICE	Omnifit HA Hip Stem	Total Hip Replacement with Omnifit HA Hip Stem

Timeline

• Start date: 1987-10-01
• Primary completion: 2011-05-01
• Completion: 2011-05-01
• First posted: 2009-08-13
• Last updated: 2014-08-19
• Results posted: 2014-08-19

Locations

4 sites across 2 countries: United States, Netherlands